| 1 |
Dey A, Vaishak K, Deka D, Radhakrishnan AK, Paul S, Shanmugam P, Daniel AP, Pathak S, Duttaroy AK, Banerjee A. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review. Infection 2023;:1-16. [PMID: 36906872 DOI: 10.1007/s15010-023-02017-8] [Reference Citation Analysis]
|
| 2 |
Ghulam U, Nazim F, Farooqui N, Rizwan-Ul-Hasan S, Anwar MF, Ahmed K, Jamal A, Kayani HA, Mughal N, Hussain A, Sarria-Santamera A, Abidi SH. Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases. PLoS One 2022;17:e0279270. [PMID: 36584119 DOI: 10.1371/journal.pone.0279270] [Reference Citation Analysis]
|
| 3 |
Fakharian A, Mirenayat MS, Ferdowsi F, Mirtajani SB, Khalili V, Zahiri R, Jamaati H. The Efficacy of Methylprednisolone in Clinical Manifestations, Inflammatory Biomarkers, and Antioxidant Changes in the COVID-19 Patients. Arch Clin Infect Dis 2022;17. [DOI: 10.5812/archcid-129799] [Reference Citation Analysis]
|
| 4 |
Rasmi Y, Hatamkhani S, Naderi R, Shokati A, Nayeb Zadeh V, Hosseinzadeh F, Farnamian Y, Jalali L. Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. Acta Histochem 2022;124:151908. [PMID: 35662001 DOI: 10.1016/j.acthis.2022.151908] [Reference Citation Analysis]
|
| 5 |
Lalioti V, González-Sanz S, Lois-Bermejo I, González-Jiménez P, Viedma-Poyatos Á, Merino A, Pajares MA, Pérez-Sala D. Cell surface detection of vimentin, ACE2 and SARS-CoV-2 Spike proteins reveals selective colocalization at primary cilia. Sci Rep 2022;12:7063. [PMID: 35487944 DOI: 10.1038/s41598-022-11248-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Schiuma G, Beltrami S, Bortolotti D, Rizzo S, Rizzo R. Innate Immune Response in SARS-CoV-2 Infection. Microorganisms 2022;10:501. [DOI: 10.3390/microorganisms10030501] [Reference Citation Analysis]
|
| 7 |
Hansur L, Louisa M, Wuyung PE. Approach for the study of COVID-19 infection and vaccine development using mice model: A narrative review. THE 6TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES: Proceedings of the 6th International Symposium of Biomedical Engineering (ISBE) 2021 2022. [DOI: 10.1063/5.0098285] [Reference Citation Analysis]
|
| 8 |
Zannella C, Rinaldi L, Boccia G, Chianese A, Sasso FC, De Caro F, Franci G, Galdiero M. Regulation of m6A Methylation as a New Therapeutic Option against COVID-19. Pharmaceuticals (Basel) 2021;14:1135. [PMID: 34832917 DOI: 10.3390/ph14111135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 9 |
Sethumadhavan DV, Jabeena CA, Govindaraju G, Soman A, Rajavelu A. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives. Curr Res Microb Sci 2021;2:100079. [PMID: 34725650 DOI: 10.1016/j.crmicr.2021.100079] [Reference Citation Analysis]
|
| 10 |
Piotrowicz K, Gąsowski J, Michel JP, Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res 2021;33:2887-98. [PMID: 34328636 DOI: 10.1007/s40520-021-01942-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 11 |
Zhou YW, Xie Y, Tang LS, Pu D, Zhu YJ, Liu JY, Ma XL. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther 2021;6:317. [PMID: 34446699 DOI: 10.1038/s41392-021-00733-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 12 |
AbdelHamid SG, Refaat AA, Benjamin AM, Elmawardy LA, Elgendy LA, Manolly MM, Elmaksoud NA, Sherif N, Hamdy NM. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review. Environ Sci Pollut Res Int 2021. [PMID: 34383213 DOI: 10.1007/s11356-021-15588-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Xu J, Wu Z, Zhang M, Liu S, Zhou L, Yang C, Liu C. The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2. Front Neurosci 2021;15:694446. [PMID: 34276298 DOI: 10.3389/fnins.2021.694446] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Ciarambino T, Para O, Giordano M. Immune system and COVID-19 by sex differences and age. Womens Health (Lond) 2021;17:17455065211022262. [PMID: 34096383 DOI: 10.1177/17455065211022262] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 15 |
Praissman JL, Wells L. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research. Mol Cell Proteomics 2021;20:100103. [PMID: 34089862 DOI: 10.1016/j.mcpro.2021.100103] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 16 |
Salgado-Albarrán M, Navarro-Delgado EI, Del Moral-Morales A, Alcaraz N, Baumbach J, González-Barrios R, Soto-Reyes E. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection. NPJ Syst Biol Appl 2021;7:21. [PMID: 34031419 DOI: 10.1038/s41540-021-00181-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 17 |
Lalioti V, González-sanz S, Lois-bermejo I, González-jiménez P, Viedma-poyatos Á, Merino A, A. Pajares M, Pérez-sala D. Immunolocalization studies of vimentin and ACE2 on the surface of cells exposed to SARS-CoV-2 Spike proteins.. [DOI: 10.1101/2021.05.04.442648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Mannino F, Bitto A, Irrera N. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches. Front Pharmacol 2020;11:592169. [PMID: 33633566 DOI: 10.3389/fphar.2020.592169] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 19 |
Luo W, Ige OO, Beacon TH, Su RC, Huang S, Davie JR, Lakowski TM. The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression. Genome 2021;64:400-15. [PMID: 33197212 DOI: 10.1139/gen-2020-0130] [Reference Citation Analysis]
|
| 20 |
Hussen J, Kandeel M, Hemida MG, Al-Mubarak AIA. Antibody-Based Immunotherapeutic Strategies for COVID-19. Pathogens. 2020;9. [PMID: 33167401 DOI: 10.3390/pathogens9110917] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 21 |
. Issue Highlights. IUBMB Life 2020;72:2240-2240. [DOI: 10.1002/iub.2400] [Reference Citation Analysis]
|
| 22 |
Johnson HM, Lewin AS, Ahmed CM. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19. Front Immunol 2020;11:582102. [PMID: 33193390 DOI: 10.3389/fimmu.2020.582102] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 23 |
Beacon TH, Delcuve GP, Davie JR. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus1. Genome 2021;64:386-99. [PMID: 33086021 DOI: 10.1139/gen-2020-0124] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
|
